Epigenomics: Jens Ravens

Jens Ravens, executive board member of Epigenomics, will be leaving the board effective April 30, 2024 as the company is transferring almost all of its assets to New Day Diagnostics. The firm's supervisory board will appoint a new executive board member in due course and will decide on the further composition of the board.